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Abstract. The lateral mobility of the vesicular stoma- 
titis virus spike glycoprotein (G protein) and various 
mutant G proteins produced by site-directed mutagene- 
sis of the G cDNA has been measured. Fluorescence 
recovery after photobleaching results for the wild type 
G protein in transfected COS-1 cells yielded a mean 
diffusion coefficient (D) of 8.5 (+ 1.3) × 10 -'1 cmVs 
and a mean mobile fraction of 75% (+ 3%). Eight 
mutant proteins were also examined: dTM14, lacking 
six amino acids from the transmembrane domain; 
TA2, lacking an oligosaccharide in the extracellular 
domain; QN2, possessing an extra N-linked oligosac- 
charide in the extracellular domain; CS2, possessing a 
serine instead of a cysteine at residue 489 in the cyto- 
plasmic domain, preventing palmitate addition to the 
glycoprotein; TMR-stop, lacking the entire cytoplasmic 
domain except an arginine at residue 483; and three 
chimeric proteins, G~t, G23, and GHA, containing in 
place of the 29 amino acid wild type cytoplasmic 
domain the cytoplasmic domains from the surface IgM 
from the spike protein of the infectious bronchitis vi- 
rus or from the hemagglutinin protein of the influenza 
virus, respectively. The mean D for the mutant pro- 
teins varied over a relatively small range, with the 
slowest mutant, G23, exhibiting a value of 11.3 (+ 1.4) 
x 10 -'1 cm2/s and the fastest mutant, GHA, having a 
D of 28.6 (+ 4.5) × 10-" cm2/s. The mean mobile 
fraction similarly varied over a small range, extending 
from 55 to 68 %. None of the mutations resulted in the 
more rapid diffusion characteristic of membrane pro- 
teins embedded in artificial bilayers. Therefore, it ap- 
pears that the cytoplasmic and transmembrane domains 
themselves contribute little to restraining the lateral 
mobility of this integral membrane protein when ex- 
pressed in transfected cells. 
S 
Ir~CE the advent of fluorescence recovery after photo- 
bleaching (FRAP)' (14), considerable effort has been 
devoted to elucidating the mechanisms that restrict the 
lateral mobility of molecules in cell membranes. Lateral 
diffusion measurements of proteins reconstituted into artifi- 
cial bilayers indicate diffusion coefficients (D) ~5-500 times 
greater than those of the same proteins in cell membranes 
(14). Thus, the question arises as to what cellular compo- 
nents inhibit or completely restrict lateral diffusion and with 
which structural regions of integral membrane proteins do 
these components interact. Until recently the majority of 
lateral diffusion studies were restricted to naturally occur- 
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ring proteins. In this study, using cDNAs encoding the wild 
type and eight mutants of the vesicular stomatitis virus 
(VSV) spike glycoprotein (G protein), we transfected cells 
and measured the lateral diffusion of G proteins possessing 
specific alterations in the cytoplasmic, transmembrane, and 
extracellular domain. This system permits study of defined 
alterations in the structure of a single integral membrane pro- 
tein while avoiding the cytopathic effects inherent in viral in- 
fection. Furthermore, other viral proteins (e.g., the matrix 
or M protein) with possible diffusion limiting properties are 
not present in transfected ceils, permitting study of the G mu- 
tants alone with endogenous cellular proteins. 
Materials and Methods 
Ce//s 
Initial cultures of COS-I cells were obtained from the line originally estab- 
lished by Gluzman (12). Subsequent cultures were purchased from the 
American I~ype Culture Collection (Rockville, MD). Cells were grown in 
Duibecco-Vogt's modified Eagle medium supplemented with 5% heat- 
inactivated defined FCS (Hyclone Laboratories, Logan, UT) and penicillin 
(100 U/ml) streptomycin (100 lag/ml); (GIBCO, Grand Island, NY). 
© The Rockefeller University Press, 0021-9525/87/07/69/7 $2.00 
The Journal of Cell Biology, Volume 105, July 1987 69-75 69 
Transfection 
Cells plated on coverslips in 35-mm dishes were transfected by incubation 
at 37°C in 0.75 ml Tris-saline containing 10 Ilg/ml of the appropriate plasmid 
and DEAE-dextran (2 x 106 mol wt; Pharmacia Fine Chemicals, Div, 
Pharmacia Inc., Piscataway, NJ) at a concentration of 500 ttg/ml. After 30 
min the Tris-DNA solution was removed. 1 ml of complete media contain- 
ing 100 ~tM chloroquine (Sigma Chemical Co., St. Louis, MO) was then 
added and the dishes returned to the 37°C incubator. After 2.5-3.5 h, the 
coverslips were rinsed twice with complete media and placed in a new dish 
containing 2 ml of fresh media (2). FRAP measurements were performed 
36-47 h later. Plasmids encoding the wild type and the mutant proteins CS2, 
dTM14, TA2, QN2, Glx, GHA, and G23 were prepared as previously de- 
scribed (1, 2, 23, 26, 28). The plasmid for TMR-stop was prepared using 
similar techniques. 
Antibodies 
Douglas S. Lyles (Bowman Grey School of Medicine, Wake Forest Univer- 
sity, Winston-Salem, NC) kindly provided a mouse anti-VSV protein mono- 
clonal antibody (19). Lissamine rhodamine B sulfonyl chloride (Molecular 
Probes, Junction City, OR) was covalently attached to the antibody as fol- 
lows: the pH of purified IgG (minimum concentration of I mg/ml) in PBS 
was adjusted to pH 9.0 with 1 M sodium bicarbonate buffer (pH 9) in a ratio 
of 4:1 (vol/vol). A rhodamine stock solution was prepared in acetone and 
added to the antibody solution in 5 aliquots at 10-min intervals. The final 
rhodamine/antibody molar ratio was 20:50, the higher ratios being used for 
the lower antibody concentrations. The conjugated antibody was separated 
from free dye by gel filtration chromatography using a Sephadex G-50 
column (Pharmacia Fine Chemicals). The conjugated antibody was dia- 
lyzed exhaustively against PBS. 
Fab fragments of rhodamine conjugated anti-G antibody were prepared 
by papain digestion (immobilized papain; Pierce Chemical Co., Rockford, 
IL) for 1 h at 37°C. The reaction products were passed over a protein A 
affinity column (Atli-Gel Protein A; Bio-Rad Laboratories, Richmond, CA) 
to remove any undigested and partially digested material containing the F, 
moiety. SDS gel electrophoresis gave bands characteristic of Fab fragments 
and confirmed that no significant amount of intact IgG was present. The 
resulting solution was concentrated using a Centricon-10 (Amicon Corp., 
Scientific Sys. Div., Danvers, MA) and dialyzed against PBS. 
Lipid Labeling 
COS-1 cells were labeled with 1-acyl-2(N-4-nitrobenzo-2oxa-l,3 diazole 
amino caproyl) phosphatidylcholine (NBD-PC; Avanti Polar Lipids, Inc., 
Birmingham, AL) as follows. A 25 nM suspension of NBD-acyl-PC in PBS 
was sonicated for 1 h at 4°C. This suspension was incubated with cells for 
1 h at 4°C; cells were then washed with PBS, and colabeled with rhodamine 
anti-G Fab fragments if required as described below. 
FRAP Measurements 
Coverslips to be labeled with antibody were washed twice in PBS, soaked 
5 rain in PBS containing 1% BSA (Sigma Chemical Co.) to reduce 
nonspecific staining, stained by inverting the coverslip on a 15-1~1 droplet 
of an anti-G-Fab fragment (in PBS) solution, and mounted on metal slides. 
Coverslips were discarded after no more than 70 min on the FRAP micro- 
scope stage. All procedures were carried out at room temperature. FRAP 
measurements and subsequent calculations of D were performed as previ- 
ously described (15). 
Results 
Lateral Diffusion of Wild ~ype G 
We initially measured the diffusion coefficient of the wild 
type G protein to establish a baseline for comparison with 
the mutant G proteins. The diffusion coefficients (D) varied 
considerably; however, •75 % of the sampled cells exhibited 
Ds ranging from 1.0 to 10.0 x 10 -I1 cm2/s and 50% of the 
sampled data fell in the narrow range extending from 4.0 to 
8.0 × 10 -11 cm2/s (Fig. 1 A, top). Similarly the mobile frac- 
tion showed a strong central tendency with 50 % of the cells 
exhibiting recovery ranging from 80 to 100%. Overall the 
mean D was 8.5 (+ 1.3) × 10 -u cm2/s and the mean mobile 
fraction was 75% (+ 3%). 
We also measured the lateral diffusion of G protein in VSV- 
infected COS-1 cells. Previous experiments (16, 27) demon- 
strated that G protein in VSV-infected cells has a diffusion 
coefficient of (4-8.5) × 10 -~° cmVs, regardless of the time 
after infection. Our results indicate a strong time dependency 
with diffusion decreasing or disappearing altogether at 6 h 
after infection. Overall, for those cells that did exhibit dif- 
fusion, we calculated a mean D of 2.3 × 10 -j° (_  1.3) 
cm2/s and a mean mobile fraction of 59% (+ 10). We have 
at present no explanation to account for the discrepancy in 
results. A possible source of restraint to lateral mobility may 
lie in the SV-40 used to transform the CV-1 cells that give rise 
to COS-1 cells. Reidler et al. (27) found that G protein in 
VSV-infected SV3T3 cells (3T3 cells transformed by SV-40) 
exhibited a remarkably reduced mobile fraction (from 68 to 
29%). 
Lateral Diffusion of Mutant Forms of G 
We examined eight mutant forms of G protein: QN2, pos- 
sessing an asparagine instead of a glutamine at residue 280, 
creating a new glycosylation signal yielding a protein with 
three N-linked oligosaccharides; TA2, containing an ala- 
nine in place of a threonine at residue 338, disrupting the 
asparagine-glycine-threonine glycosylation signal, and thus 
preventing oligosaccharide addition at asparagine 336; 
dTM14, a mutant lacking six amino acids from the middle 
of the transmembrane domain; TMR-stop, lacking the entire 
cytoplasmic domain except an arginine at residue 483; CS2, 
possessing a serine instead of a cysteine at residue 489 in the 
cytoplasmic domain, preventing palmitate addition to the 
glycoprotein; G23, a chimera possessing the extracellular 
and transmembrane domains of G protein and the first three 
cytoplasmic domain amino acids from G protein followed by 
128 amino acids from the cytoplasmic domain of the E1 gly- 
coprotein of the infectious bronchitis virus; G~t, containing 
the surface IgM cytoplasmic domain (Lys-Val-Lys) in place 
of the 29 amino acid wild type sequence; and GHA, a chi- 
mera containing extracellular and transmembrane domains 
of G protein followed by the cytoplasmic domain from the 
hemagglutinin protein of the influenza virus. Previously, cor- 
rect construction of the mutant and wild type plasmids was 
determined by digestion with restriction endonucleases and 
by DNA sequence analysis. Furthermore, immunoprecipita- 
tion of the mutant proteins, followed by SDS-PAGE analysis, 
verified that the cDNAs encoded a protein of the predicted 
molecular weight (1, 23, 24, 26, 28, 29). The results in terms 
of distributions of D and mobile fraction values over the cell 
population examined are given in Fig. 1 (A-C) and summa- 
rized in Table I. FRAP measurements on these proteins 
yielded mean diffusion coefficients ranging from 11.3 x 
10 -n cmE/s to  28.6 X 10 -It cmE/s and mean mobile fractions 
from 55 to 68% (see Table I). 
On the whole each mutant exhibited a wider range of 
diffusional behavior than the wild type G protein, with stan- 
dard errors of the mean equaling two and three times that of 
the wild-type. Two exceptions to this large variation in diffu- 
sion coefficients were QN2 [D = 13.1 (+ 2.0) x 10 -I~ 
cm2/s] and G23 [D = 11.3 (+__ 1.4) × 10-" cm2/s], both of 
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Figure 1. Distribution of the diffusion coefficients and mobile frac- 
tions for wild type and mutant G proteins. (Left) Schematic render- 
ing of VSV G wild type and mutant structures after Damell et al. 
(4). (Center and righO Histograms showing number of cells exhibit- 
ing a diffusion coefficient ( I )  or mobile fraction (%) within the 
specified range. Scales normalized to maxima. (A) Wild type G 
(top) and extracellular domain mutations; (center) mutant QN2 in 
which Asn substituted for Gin(264) provides an extra glycosylation 
site; (bottom) mutant TA2 in which Ala substituted for Thr(322) 
prevents glycosylation at Asn(320). (B) Cytoplasmic and trans- 
membrane mutations: (top) mutant dTM14 in which the transmem- 
brahe domain is shortened from 20 to 14 amino acids; (center) mu- 
tant TMR-stop in which the entire cytoplasmic domain is deleted 
except Arg (467); (bottom) mutant CS2 in which Set substituted for 
Cys (473) prevents acylation at Cys (473). (C) Chimeric mutations: 
(top) mutant (323, cytoplasmic domain from infectious bronchitis 
virus glycoprotein substituted for VSV G protein cytoplasmic do- 
main; (center) mutant G~t, cytoplasmic domain of G replaced with 
Lys-Val-Lys sequence; (bottom) mutant GHA, cytoplasmic domain 
from the influenza virus hemagglutinin protein substituted for VSV 
G protein cytoplasmic domain. 
which showed fairly consistent diffusional behavior (see Fig. 
l, A middle and C top). 
In our experiments we noticed large temporal variations in 
the fluorescence intensity within the region interrogated by 
the measuring laser beam of the FRAP apparatus. Subse- 
quent monitoring of the cell surface with the FRAP instru- 
ment without bleaching indicated that the variations in fluo- 
rescence intensity were due to fluctuations at the cell surface 
unrelated to FRAP bleaching. These fluctuations made it im- 
possible to analyze some of the FRAP curves. In an attempt 
to investigate the source of fluorescence variation, we ob- 
served live cells with digitized fluorescence microscopy (5). 
G-transfected cells stained with rhodaminated IgG gave 
bright staining, particularly of structures presumed to be 
microvilli. Digital analysis revealed that fluorescence inten- 
sity changes within selected areas were directly related to the 
movement of these putative microvilli. However, we were 
unable to attribute fluorescence intensity changes to micro- 
villar movement when using the dimmer image provided by 
the rhodaminated Fob fragment. 
Control Studies 
To rule out the possibility of a systematic effect on the 
diffusion coefficient or mobile fraction due to the length of 
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Table I. Mean Diffusion Coefficients (D) and Mobile Fractions (MF) for Wild Type G and Mutant G Proteins* 
Protein Mutation D (× 10 ~ cm2/s) MF n 
Wild type G None 8.5 + 1.3 75 + 3 
QN2 Asn substituted for Gln(264) provides extra 
glycosylation site 13.1 ___ 2.0 55 + 5 
TA2 Ala substituted for Thr(322) prevents glycosylation at 
Asn(320) 17.5 +_ 2.6 65 + 4 
dTM14 Transmembrane  domain shortened from 20 to 14 
amino acids 19.0 + 3.3 62 + 5 
TMR-stop Entire cytoplasmic domain deleted except Arg(467) 20.7 + 3.4 65 + 4 
CS2 Ser substituted for Cys(473) prevents acylation at 
Cys(473) 22.6 4- 2.8 66 + 5 
G23 Cytoplasmic domain from infectious bronchitis virus 
glycoprotein substituted for VSV G protein cytoplas- 
mic domain 
Cytoplasmic domain replaced with Lys-Val-Lys 
Cytoplasmic domain from the influenza virus hemmag- 










11.3 + 1.4 64 + 5 26 
21.1 + 4.3 66 + 4 25 
28.6 + 4.5 68 + 4 27 
*COS-I ceils previously plated on coverslips and transfected with the appropriate vector were labeled with an Fab fragment of a rhodaminated anti-G protein 
monoclonal antibody and subjected to FRAP measurement as previously described (15). Values are +SEM. 
time after transfection, we plotted D and the mobile fraction 
versus the time after transfection with wild type cDNA (data 
not shown). No correlation was found. Similarly, we plotted 
the mobile fraction versus D; again, no correlation was ap- 
parent (data not shown). These experiments demonstrated 
that neither the level of expression of the vector nor the state 
of replication of the vector, both of which vary with time, 
affect the lateral diffusion of G protein. 
Lateral diffusion of the lipid probe, NBD-PC, in the 
plasma membrane of COS-1 cells in both mock-transfected 
ceils and in cells transfected with the gene for wild type G 
was also measured to assess the possible effect of the amount 
of G protein expressed at the plasma membrane. This experi- 
ment required double labeling. First, all ceils in the culture 
were labeled with NBD-PC; then the culture was counter 
stained with rhodamine anti-G Fab. Rhodamine optics al- 
lowed identification of those cells in the culture that were ex- 
pressing wild type G at the plasma membrane. Subsequent 
FRAP measurements with fluorescein optics allowed mea- 
surement of the NBD-PC diffusion coefficient in the trans- 
fected cells. Control values were obtained from nonexpress- 
ing cells in the same culture or in separate mock transfected 
cultures that had been labeled with NBD-PC. No significant 
difference was found in the lipid analogue lateral diffusion 
coefficients between mock-transfected or nonexpressing ceils 
and transfected ceils (data not shown). 
The effect of possible multivalent aggregates of anti-G Fab 
fragments was tested by labeling the cells with Fab prepara- 
tions that had been previously centrifuged at 100,000 g. No 
appreciable change in the measured diffusion coefficients 
was effected by this procedure. 
Discuss ion  
Transfection of vectors, containing wild type and mutated 
genes of various proteins, into selected recipient cells offer 
model systems in which structure-function relationships can 
be examined. Two previous studies have examined the effect 
of site-directed truncations of the cytoplasmic domain on the 
lateral diffusion coefficient of the H-2 murine histocompati- 
bility antigen (9) and the epidermal growth factor receptor 
(21). Both studies detected little effect of such truncations on 
the lateral diffusion coefficient of these proteins. This study 
extends this line of experimentation to another integral mem- 
brane protein, the VSV G protein, examining the effects of 
alterations in the extracellular, transmembrane, and cyto- 
plasmic domains on the lateral mobility of G protein. We 
studied G proteins with a mutation in the extracellular do- 
main that either lacked or contained an additional N-linked 
oligosaccharide. We also examined a G protein that lacked 
six of the 20 amino acid residues from the membrane-an- 
choring domain yet has the same extracellular and cytoplas- 
mic domains of the wild type G protein (1). In addition, two 
types of mutations in the cytoplasmic domain of the G pro- 
tein were examined, one that eliminates the site for palmitate 
acylation and another type that examines the effect of sub- 
stituting the cytoplasmic domains from different integral 
membrane proteins for the cytoplasmic domain of the G 
protein. 
In considering the behavior of the wild type and mutant 
G proteins in the plasma membrane, it is helpful to recall 
the possible sources of restraint to protein lateral mobility. 
Membrane proteins will exhibit decreased diffusion through: 
(a) increased protein concentration leading to crowding 
within the membrane as well as decreased membrane flu- 
idity; (b) self-association, leading to dimer, trimer, and other 
larger multimers; (c) specific or nonspecific association with 
other membrane proteins, leading to larger, more slowly 
diffusing protein complexes; and (d) association with ex- 
traceUular or cytoplasmic structures that could prevent or de- 
crease diffusion. 
Several million copies of G can be expressed in transfected 
cells, prompting the consideration that this amount of protein 
added to the plasma membrane may result in reduced diffu- 
sion coefficients of membrane components. However, simi- 
lar NBD-PC diffusion coefficients were measured in mock- 
transfected and wild type G-transfected cells indicating that 
this amount of additional plasma membrane protein did not 
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appreciably obstruct the diffusion of the diI probe or gener- 
ally decrease plasma membrane fluidity. This is a plausible 
result considering the following comparison. In a COS cell 
having 2 x 106 plasma membrane copies of G in a 
2,000 ~tm 2 surface area, G is expressed at a surface density 
of 1,000/~tm 2. Acetylcholine receptor in plaques can be 
found in surface densities of 10,000/lxm 2 (31). This receptor 
most likely occupies a far larger cross-sectional area in the 
membrane plane allowing us to estimate that in transfected 
cells G occupies a maximum of 2--4 % of the available mem- 
brane area. Theoretical treatments show that such an incre- 
ment in fractional area coverage is too small to appreciably 
affect probe lateral diffusion (see, for example, reference 
32). 
The self-aggregation state of G is not well established. In 
reconstituted bilayer systems, energy transfer studies suggest 
that G exists as a monomer and any unusual treatment con- 
verts it to a multimer (Parce, W., personal communication). 
In infected cells detergent solubilization of a naturally occur- 
ring secreted form of G protein fails to reveal anything but 
monomer G. On the other hand, monoclonal antibody quick- 
ly patches G at the cell surface, indicating either a repeated 
epitope on the molecule or a multimeric complex (Parce, W., 
personal communication). Furthermore, recent studies sug- 
gest that G forms oligomers at least during transport to the 
surface of infected cells (18). The hemagglutinin of influenza 
virus exists in mature form as a trimer (35) which is assem- 
bled before transport out of the endoplasmic reticulum (11). 
The generalized increase in D values seen with mutants 
could be attributed to reduced oligomerization of the G pro- 
tein due to conformational changes induced by the various 
mutations. Reduced patching upon addition of monoclonal 
anti-G IgG might be expected when more monomeric anti- 
gen is present. Qualitatively no gross alteration in either the 
patch pattern or its relationship with subjacent spectrin was 
noticed when transfected cells were expressing G or G~t. 
With respect to association with other membrane proteins, 
no such interactions have been demonstrated, but as dis- 
cussed below, relatively weak interactions with other mem- 
brane proteins cannot be excluded. 
It is likely that the major reduction in the G lateral 
diffusion coefficients relative to the values expected in simple 
bilayers is due to the interactions of this protein either 
directly or indirectly (via other membrane proteins) with 
structures peripheral to the plasma membrane (10, 14, 15, 
17). For example, in VSV-infected cells, Reider et al. (27) 
have demonstrated that the M protein in infected cells does 
lower the mobile fraction of G protein, but no effect on the 
mobility of the diffusing population was observed. 
In this context, it is of interest to inquire which parts of 
the G molecule are involved in these proposed mobility 
retarding interactions. In general, any change in the cytoplas- 
mic domain generated at most an approximate threefold in- 
crease in the diffusion coefficient, as occurred with GHA [D 
= 28.6 (+ 4.5) × 10 -1~ cm2/s]. G~t, CS2, GHA, and TMR- 
stop all possessed mean diffusion coefficients in the range of 
20.7-28.6 x 10 -~ cm2/s. Shortening the transmembrane do- 
main, as with dTM14, also exacted a small increase in the 
diffusion coefficient, raising the mean value to 19.0 (+ 3.3) 
× 10 -H cm2/s. Changes in extracellular glycosylation (each 
oliogosaccharide having a mass of '~3,000 D and comprising 
,~15 residues) elicited a still smaller effect, barely affecting 
the diffusion coefficient in the case ofQN2 [D = 13.1 (+ 2.0) 
× 10-1Vs]. Similarly, G23, with its 130 amino acid cytoplas- 
mic domain showed a marginal increase in diffusion. These 
effects on lateral diffusion rates are relatively minor when 
compared with the fact that membrane proteins diffuse at 
least 100-fold faster in simple lipid bilayers with no sig- 
nificant immobile fraction (34). 
It should be noted that the variation in lateral diffusion 
coefficients between the mutants does not correlate at all with 
variation in transport rates from endoplasmic reticulum to 
Golgi seen for some of the mutants (measured as half-time 
for acquisition of endo H resistance; see Table II). This lack 
of correlation can be explained by two possibilities: (a) al- 
though lateral mobility may be necessary for intracellular 
transport in order to allow clustering into specialized regions 
of the endoplasmic reticulum and the Golgi complex, lateral 
diffusion is not a rate-limiting determinant of intracellular 
transport; (b) lateral diffusion is the rate-limiting factor 
affecting intracellular transport, but the mechanisms in the 
endoplasmic reticulum and the Golgi complex governing 
lateral diffusion differ from those at the plasma membrane; 
hence, mutations altering lateral mobility at the plasma 
membrane may not significantly affect lateral mobility in in- 
tracellular membranes. The disparate environments found in 
the lumen of the endoplasmic reticulum and the extracellular 
matrix render the latter hypothesis plausible. 
The fact that none of the mutations tested produced a large 
(order of magnitude) change in the protein diffusion coeffi- 
cients restricts the search for the factors restraining the later- 
al mobility of certain membrane proteins. It is likely that the 
cytoplasmic domain is not a crucial region in determining the 
mobility of this protein. These results are consistent with the 
previous work on the mouse H-2 antigen (9) and the epider- 
mal growth factor receptors (21), in which cytoplasmic dele- 
tions elicited only small changes in protein diffusion. It 
should be noted that in cases where the membrane protein 
is known to be anchored by cytoskeletal components, such 
as band 3 in the erythrocyte membrane (for review see refer- 
ence 3) or the band 3 analogue in kidney epithelium (7), mu- 
tations in the cytoplasmic domain could be expected to in- 
crease the lateral diffusion markedly if they interfered with 
the interaction of band 3 with ankyrin or with ankyrin ana- 
Table II. Lack of Correlation of the Lateral Diffusion 
CoeJficient for Wild Type and Mutant G Proteins with Their 
Rates of Transport*from Endoplasmic Reticulum 
to the Golgi 
Protein:~ D (× 10 u cm:/s)§ (Transport rate) -~ Reference 
min 
Wild type G 8.5 15-20 8, 29 
QN2 13. I 15-20 36 
TA2 17.5 15-20 36 
dTMI4 19.0 15-20 6 
CS2 22.6 15-20 5 
G23 11.3 25 8 
Gg 21.1 110-120 8 
GHA 28.6 55-60 8 
* Measured as the half-time for acquisition of endo H resistance. 
~: As defined in Table I. 
§ As stated in Table I; standard errors given in Table I. 
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logues. It is also clear that portions of the cytoplasmic do- 
main are crucial for the clustering in coated pits that precedes 
internalization of the low density lipoprotein receptor (20) 
and epidermal growth factor receptor (22) and for efficient 
transport of some proteins to the cell surface after biosynthe- 
sis (6, 26, 30, 37). 
Second, the small change in diffusion coefficient seen with 
dTM14 raises questions regarding the importance of the 
transmembrane domain to diffusion. As previous experi- 
ments have suggested that the transmembrane deletion leaves 
the cytoplasmic and extracellular domains unaltered (1), the 
reduction from 20 to 14 amino acids in the membrane- 
spanning domain must alter the alpha-helical structure in this 
domain. The failure of the conformational change to exact 
a significant alteration in diffusive behavior suggests that the 
transmembrane domain plays little or no direct role in limit- 
ing lateral mobility of G in the plasma membrane. 
Two general mechanisms remain to explain reduced diffu- 
sion coefficients of many plasma membrane components. In 
the case of the G glycoproteins, the large extracellular do- 
main of 462 residues may be the principal determinant of its 
lateral diffusion in COS-1 cells. The determinant apparently 
does not reside solely in the two ~o3,000-D oligosaccharides 
as neither addition of one chain nor deletion of one chain ap- 
preciably affects lateral diffusion. This, in spite of the fact 
that the charge and hydration of such polysaccharide "trees" 
suggests that they extend from the protein body ,,035/~ into 
the extracellular space. To understand the nature of these re- 
straints, it will be important to examine other alterations in 
this domain that retain the capacity to be transported to the 
cell surface. While the Fab ligand could conceivably also 
contribute to the reduced mobility of G and the various mu- 
tants, several recent experiments argue that the mobility re- 
straints observed are due to interactions involving the mem- 
brane protein itself with the extracellular matrix. McCloskey 
and Poo (25) have shown that the lateral mobility of the Fc 
receptor in rat basophilic leukemia cells is about the same 
whether measured in the presence or absence of the IgE 
ligand. Furthermore, cellular FRAP measurements of the 
Thy 1 antigen using monoclonal IgG antibodies (13) and the 
H-2 murine histocompatibility antigen using Fab fragments 
of anti-H-2 antibody have (8) produced values in excess of 
1 × 10 -9 cm2/s for a fraction of these proteins; such results 
suggest that rapid diffusion can be measured by FRAP in the 
preser/ce of a bound antibody label. 
The alternative to the ectodomain restraints to lateral diffu- 
sion would be a second system of membrane proteins (2a) 
that interact both with peripheral structures and with certain 
membrane proteins, such as G, to reduce the lateral diffusion 
coefficients of such proteins. Such a system has been invoked 
by Singer et al. (33) to recognize those membrane proteins 
cross-linked into "patches". 
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